IN8BIO INC (INAB:NASDAQ)
$1.44 -0.01 (-0.6897%)
Analysed IN8BIO INC (INAB:NASDAQ) News Sources
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
07-04-2026
yahoo.com
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03-04-2026
yahoo.com
IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
12-03-2026
yahoo.com
IN8bio to Present at TD Cowen 46th Annual Health Care Conference
24-02-2026
yahoo.com
IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer
09-02-2026
yahoo.com
IN8bio to Present at Upcoming Investor and Scientific Conferences in February
03-02-2026
yahoo.com
IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma
12-01-2026
yahoo.com
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager
19-12-2025
yahoo.com
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights
06-11-2025
yahoo.com
IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
29-10-2025
yahoo.com
What is the current price of IN8BIO INC (INAB:NASDAQ)?
The current price of IN8BIO INC (INAB:NASDAQ) is $1.44.
IN8BIO INC (INAB:NASDAQ) absolute price change since previous trading day?
The absolute price change of IN8BIO INC (INAB:NASDAQ) since the previous trading day is $-0.01.
IN8BIO INC (INAB:NASDAQ) percentage price change since previous trading day?
The percentage price change of IN8BIO INC (INAB:NASDAQ) since the previous trading day is -0.6897%.
What is the most recent average sentiment score for IN8BIO INC (INAB:NASDAQ)?
The most recent average sentiment score for IN8BIO INC (INAB:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for IN8BIO INC (INAB:NASDAQ)?
The most recent sentiment for IN8BIO INC (INAB:NASDAQ) is .
SEC-8K** Filing Available For IN8BIO INC (INAB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.